Literature DB >> 31563937

Hepatitis C Virus Elimination Requires More Than Good Drugs.

Oluwaseun Falade-Nwulia1.   

Abstract

Year:  2020        PMID： 31563937      PMCID： PMC7442844          DOI： 10.1093/cid/ciz963

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.

Authors:  Tengiz Tsertsvadze; Amiran Gamkrelidze; Nikoloz Chkhartishvili; Akaki Abutidze; Lali Sharvadze; Vakhtang Kerashvili; Maia Butsashvili; David Metreveli; Lia Gvinjilia; Shaun Shadaker; Muazzam Nasrullah; Ekaterine Adamia; Stefan Zeuzem; Nezam Afdhal; Sanjeev Arora; Karla Thornton; Beth Skaggs; Tinatin Kuchuloria; Maia Lagvilava; David Sergeenko; Francisco Averhoff
Journal:  Clin Infect Dis       Date:  2020-08-22       Impact factor: 9.079

2.  Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease.

Authors:  Lisa I Backus; Pamela S Belperio; Troy A Shahoumian; Larry A Mole
Journal:  Hepatology       Date:  2018-05-15       Impact factor: 17.425

3.  Direct-acting antiviral sustained virologic response: Impact on mortality in patients without advanced liver disease.

Authors:  Lisa I Backus; Pamela S Belperio; Troy A Shahoumian; Larry A Mole
Journal:  Hepatology       Date:  2018-05-14       Impact factor: 17.425

4.  Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens.

Authors:  Mark H Eckman; John W Ward; Kenneth E Sherman
Journal:  Clin Gastroenterol Hepatol       Date:  2018-09-08       Impact factor: 11.382

Review 5.  Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review.

Authors:  Oluwaseun Falade-Nwulia; Catalina Suarez-Cuervo; David R Nelson; Michael W Fried; Jodi B Segal; Mark S Sulkowski
Journal:  Ann Intern Med       Date:  2017-03-21       Impact factor: 25.391

6.  Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States.

Authors:  Joshua A Barocas; Abriana Tasillo; Golnaz Eftekhari Yazdi; Jianing Wang; Claudia Vellozzi; Susan Hariri; Cheryl Isenhour; Liisa Randall; John W Ward; Jonathan Mermin; Joshua A Salomon; Benjamin P Linas
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 20.999

7.  Launch of a Nationwide Hepatitis C Elimination Program--Georgia, April 2015.

Authors:  Kiren Mitruka; Tengiz Tsertsvadze; Maia Butsashvili; Amiran Gamkrelidze; Paata Sabelashvili; Ekaterine Adamia; Mari Chokheli; Jan Drobeniuc; Liesl Hagan; Aaron M Harris; Tea Jiqia; Ana Kasradze; Stephen Ko; Vakhtang Qerashvili; Lali Sharvadze; Irina Tskhomelidze; Valeri Kvaratskhelia; Juliette Morgan; John W Ward; Francisco Averhoff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-24       Impact factor: 17.586

Review 8.  Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.

Authors:  Justin R Bailey; Eleanor Barnes; Andrea L Cox
Journal:  Gastroenterology       Date:  2018-09-27       Impact factor: 22.682
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.